Trial intelligence / Profile preview

MiraLAX vs Golytely for Colonoscopy Bowel Prep

NCT00889655Phase 4Unknown

Sponsor
Oregon Health & Science University
Start
May 2009
Primary completion
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of macrogol, sponsored by Oregon Health & Science University. Primary endpoint: Boston Bowel Prep Survey. Status: unknown.

02

Drugs

macrogol

Beyond the preview

Go deeper on NCT00889655.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00889655.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call